Literature DB >> 2565325

A murine monoclonal antibody that recognizes an extracellular domain of the human c-erbB-2 protooncogene product.

T Masuko1, K Sugahara, M Kozono, S Otsuki, T Akiyama, T Yamamoto, K Toyoshima, Y Hashimoto.   

Abstract

A murine IgM monoclonal antibody, designated SV2-61, was generated against human c-erbB-2 gene-transfected NIH-3T3 (SV11) cells. SV2-61 defined a 185-kDa molecule present on the surface of SV11 cells, another line of c-erbB-2 gene-transfected NIH-3T3 (A4-15) cells, and MKN-7 human gastric cancer cell line carrying an amplified human c-erbB-2 gene. The SV2-61-defined antigen was found to show protein kinase activity in vitro. The SV2-61 was reactive with human c-erbB-2 gene-transfected NIH-3T3 cell lines but not with transfectants carrying c-erbB-2 gene mutants which lack a coding region for the extracellular domain. It was reactive with a portion of human epithelial cell lines but not with native NIH-3T3, TGF-alpha-coding gene-, activated c-raf gene- or Ha-ras gene-transfected NIH-3T3 cells, or non-epithelial human cells. These results indicate that the SV2-61 is an antibody which recognizes an extracellular domain of the c-erbB-2 gene product, 185-kDa protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565325      PMCID: PMC5917689          DOI: 10.1111/j.1349-7006.1989.tb02237.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  19 in total

1.  Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.

Authors:  S Fukushige; K Matsubara; M Yoshida; M Sasaki; T Suzuki; K Semba; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

2.  The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity.

Authors:  T Akiyama; C Sudo; H Ogawara; K Toyoshima; T Yamamoto
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

3.  Expression of the c-erbB-2 protein in normal and transformed cells.

Authors:  W J Gullick; M S Berger; P L Bennett; J B Rothbard; M D Waterfield
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

4.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.

Authors:  T Yamamoto; S Ikawa; T Akiyama; K Semba; N Nomura; N Miyajima; T Saito; K Toyoshima
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

5.  Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies.

Authors:  J A Drebin; V C Link; D F Stern; R A Weinberg; M I Greene
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines.

Authors:  Y H Xu; N Richert; S Ito; G T Merlino; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene.

Authors:  J A Drebin; D F Stern; V C Link; R A Weinberg; M I Greene
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

9.  Role of iron chelators in growth-promoting effect on mouse hybridoma cells in a chemically defined medium.

Authors:  N Yabe; M Kato; Y Matsuya; I Yamane; M Iizuka; H Takayoshi; K Suzuki
Journal:  In Vitro Cell Dev Biol       Date:  1987-12

10.  Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.

Authors:  J Yokota; T Yamamoto; K Toyoshima; M Terada; T Sugimura; H Battifora; M J Cline
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

View more
  11 in total

1.  Simultaneous Assay of ErbB-2 Protein and Carcinoembryonic Antigen in Cyst Fluid as an Aid in Diagnosing Cystic Lesions of the Breast.

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

2.  Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells.

Authors:  N E Hynes; D Taverna; I M Harwerth; F Ciardiello; D S Salomon; T Yamamoto; B Groner
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

3.  Evaluation of immunohistochemistry and enzyme linked immunosorbent assay for HER-2/neu expression in breast carcinoma.

Authors:  Rani James; K Thriveni; Girija Ramaswamy; Lakshmi Krishnamoorthy; Geetashree Mukherjee; P P Vijayalaxmi Deshmane; P P Bapsy
Journal:  Indian J Clin Biochem       Date:  2008-12-20

4.  17 beta-estradiol mimics ligand activity of the c-erbB2 protooncogene product.

Authors:  S Matsuda; Y Kadowaki; M Ichino; T Akiyama; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

5.  Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.

Authors:  S Suzuki; K Inoue; A Hongoh; Y Hashimoto; Y Yamazoe
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth.

Authors:  I M Harwerth; W Wels; J Schlegel; M Müller; N E Hynes
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

7.  Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.

Authors:  Y Nakamura; Y Tokuda; M Iwasawa; H Tsukamoto; M Kidokoro; N Kobayashi; S Kato; T Mitomi; S Habu; T Nishimura
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

8.  Cytotoxicity of anti-c-erbB-2 immunoliposomes containing doxorubicin on human cancer cells.

Authors:  S Suzuki; S Uno; Y Fukuda; Y Aoki; T Masuko; Y Hashimoto
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

9.  Construction of immunoradiometric assay for circulating c-erbB-2 protooncogene product in advanced breast cancer patients.

Authors:  M Hosono; T Saga; H Sakahara; H Kobayashi; M Shirato; K Endo; T Yamamoto; T Akiyama; K Toyoshima; J Konishi
Journal:  Jpn J Cancer Res       Date:  1993-02

10.  In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells.

Authors:  S Mori; Y Mori; T Mukaiyama; Y Yamada; Y Sonobe; H Matsushita; G Sakamoto; T Akiyama; M Ogawa; M Shiraishi
Journal:  Jpn J Cancer Res       Date:  1990-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.